Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues.

[1]  Ralph Weissleder,et al.  Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug , 2015, Nature Communications.

[2]  Yaping Tian,et al.  Expression of Sox2 in breast cancer cells promotes the recruitment of M2 macrophages to tumor microenvironment. , 2015, Cancer letters.

[3]  B. Faddegon,et al.  TH2-Polarized CD4+ T Cells and Macrophages Limit Efficacy of Radiotherapy , 2015, Cancer Immunology Research.

[4]  E. Marbán,et al.  Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting , 2014, Nature Communications.

[5]  Will Liao,et al.  The cellular and molecular origin of tumor-associated macrophages , 2014, Science.

[6]  S. Vinogradov,et al.  Macrophages associated with tumors as potential targets and therapeutic intermediates. , 2014, Nanomedicine.

[7]  M. Moseley,et al.  Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study. , 2014, The Lancet. Oncology.

[8]  Jianghong Rao,et al.  Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy. , 2014, Small.

[9]  R. Weissleder,et al.  Imaging macrophages with nanoparticles. , 2014, Nature materials.

[10]  Chun Li,et al.  A targeted approach to cancer imaging and therapy. , 2014, Nature materials.

[11]  Jan Grimm,et al.  Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle , 2014, Nature Communications.

[12]  F. Klamt,et al.  The prognostic impact of tumor-associated macrophages and intra-tumoral apoptosis in non-small cell lung cancer. , 2014, Histology and histopathology.

[13]  J. Witjes,et al.  Ferumoxtran-10 ultrasmall superparamagnetic iron oxide-enhanced diffusion-weighted imaging magnetic resonance imaging for detection of metastases in normal-sized lymph nodes in patients with bladder and prostate cancer: do we enter the era after extended pelvic lymph node dissection? , 2013, European urology.

[14]  U. Kolb,et al.  Structural characterization of iron oxide/hydroxide nanoparticles in nine different parenteral drugs for the treatment of iron deficiency anaemia by electron diffraction (ED) and X-ray powder diffraction (XRPD). , 2013, Journal of pharmaceutical and biomedical analysis.

[15]  A. Butte,et al.  A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. , 2013, Cancer discovery.

[16]  Wei Li,et al.  SPION primes THP1 derived M2 macrophages towards M1-like macrophages. , 2013, Biochemical and biophysical research communications.

[17]  Harald Ittrich,et al.  Superparamagnetic Iron Oxide Nanoparticles in Biomedicine: Applications and Developments in Diagnostics and Therapy , 2013, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[18]  W. Reinisch,et al.  State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. , 2013, Journal of Crohn's & colitis.

[19]  H. Daldrup-Link,et al.  Somatic Differentiation and MR Imaging of Magnetically Labeled Human Embryonic Stem Cells , 2012, Cell transplantation.

[20]  Z. Liao,et al.  Feasibility and safety of magnetic-controlled capsule endoscopy system in examination of human stomach: a pilot study in healthy volunteers. , 2012, Journal of interventional gastroenterology.

[21]  C. A. Shaw,et al.  In Vivo Mononuclear Cell Tracking Using Superparamagnetic Particles of Iron Oxide: Feasibility and Safety in Humans , 2012, Circulation Cardiovascular Imaging.

[22]  L. Coussens,et al.  MR imaging of tumor-associated macrophages , 2012, Oncoimmunology.

[23]  Andrew H. Beck,et al.  Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma , 2012, Proceedings of the National Academy of Sciences.

[24]  Tej B. Shrestha,et al.  Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model , 2012, International journal of nanomedicine.

[25]  V. Labhasetwar,et al.  Oh the irony: Iron as a cancer cause or cure? , 2011, Biomaterials.

[26]  M. Kuo,et al.  Iron oxide nanoparticle-induced epidermal growth factor receptor expression in human stem cells for tumor therapy. , 2011, ACS nano.

[27]  M. Rosner,et al.  Ferumoxytol for the treatment of iron deficiency , 2011, Expert review of hematology.

[28]  M. Wendland,et al.  MRI of Tumor-Associated Macrophages with Clinically Applicable Iron Oxide Nanoparticles , 2011, Clinical Cancer Research.

[29]  K. Bhalla,et al.  Histone Deacetylase Inhibitor LAQ824 Augments Inflammatory Responses in Macrophages through Transcriptional Regulation of IL-10 , 2011, The Journal of Immunology.

[30]  Cord Sunderkötter,et al.  An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. , 2011, The Journal of clinical investigation.

[31]  J. Tidball,et al.  Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype. , 2011, Human molecular genetics.

[32]  M. Grce,et al.  Effect of ferric ions on reactive oxygen species formation, cervical cancer cell lines growth and E6/E7 oncogene expression. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[33]  V. Rasche,et al.  Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes. , 2010, Biomaterials.

[34]  C. Hadjipanayis,et al.  EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma. , 2010, Cancer research.

[35]  A. Kausz,et al.  Plasma Pharmacokinetics of Two Consecutive Doses of Ferumoxytol in Healthy Subjects , 2010, Clinical pharmacology and therapeutics.

[36]  P. Allavena,et al.  Tumor-Associated Macrophages (TAM) as Major Players of the Cancer-Related Inflammation , 2010 .

[37]  R. Pazdur,et al.  FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease , 2010, American journal of hematology.

[38]  Andrew T Nguyen,et al.  A Combinatorial Approach for Targeted Delivery using Small Molecules and Reversible Masking to Bypass Non-Specific Uptake In Vivo , 2010, Gene Therapy.

[39]  A. Kausz,et al.  Physicochemical properties of ferumoxytol, a new intravenous iron preparation , 2009, European journal of clinical investigation.

[40]  F. Benvenuto,et al.  Ascorbic acid pre-treated quartz stimulates TNF-α release in RAW 264.7 murine macrophages through ROS production and membrane lipid peroxidation , 2009, Respiratory research.

[41]  A. Kristal,et al.  Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort. , 2008, Carcinogenesis.

[42]  R. Proia,et al.  Sphingosine-1-Phosphate Induces an Antiinflammatory Phenotype in Macrophages , 2008, Circulation research.

[43]  Michael Jerosch-Herold,et al.  THE POTENTIAL OF FERUMOXYTOL NANOPARTICLE MAGNETIC RESONANCE IMAGING, PERFUSION, AND ANGIOGRAPHY IN CENTRAL NERVOUS SYSTEM MALIGNANCY: A PILOT STUDY , 2007, Neurosurgery.

[44]  Philippe Robert,et al.  Recent advances in iron oxide nanocrystal technology for medical imaging. , 2006, Advanced drug delivery reviews.

[45]  Guangjun Nie,et al.  In vivo tumor growth is inhibited by cytosolic iron deprivation caused by the expression of mitochondrial ferritin. , 2006, Blood.

[46]  M. Glei,et al.  Ferric iron increases ROS formation, modulates cell growth and enhances genotoxic damage by 4-hydroxynonenal in human colon tumor cells. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[47]  W. K. Bolton,et al.  Pharmacokinetic Study of Ferumoxytol: A New Iron Replacement Therapy in Normal Subjects and Hemodialysis Patients , 2005, American Journal of Nephrology.

[48]  D. Wodarz,et al.  Dynamical Interactions between Multiple Cancers , 2005, Cell cycle.

[49]  D. Petersen.  Alcohol, iron-associated oxidative stress, and cancer. , 2005, Alcohol.

[50]  P. Ponka,et al.  Human cytomegalovirus-induced host cell enlargement is iron dependent. , 2004, American journal of physiology. Cell physiology.

[51]  A. Gupta,et al.  Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies , 2004, IEEE Transactions on NanoBioscience.

[52]  C. Tempany,et al.  Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. , 2003, Radiology.

[53]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[54]  D. Warheit,et al.  Role of alveolar macrophage chemotaxis and phagocytosis in pulmonary clearance responses to inhaled particles: Comparisons among rodent species , 1993, Microscopy research and technique.